Hoatlin:Research Team: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
| Line 11: | Line 11: | ||
*[[Hoatlin:Bendert de Graaf, B.S., M.S.|Bendert de Graaf, B.S., M.S.]] | *[[Hoatlin:Bendert de Graaf, B.S., M.S.|Bendert de Graaf, B.S., M.S.]] | ||
*[[Michael Wallisch, Ph.D.]] | *[[Michael Wallisch, Ph.D.]] | ||
*[[ | *[[Margriet van Kogelenberg, B.S.]] | ||
*[[Ingrid Bijsmans, B.S., M.S.]] | *[[Ingrid Bijsmans, B.S., M.S.]] | ||
*[[ | *[[Tanja Reuter, Ph.D]] | ||
*[[ | *[[Melud Nabavi]] | ||
*[[ | *[[Yu Zhi]] | ||
*Paul Yoshihara, PhD. worked with us to make several monoclonal antibodies. He is now Chief Executive Officer at [http://www.najittech.com/index.html Nijit Technologies, Inc.] | *Paul Yoshihara, PhD. worked with us to make several monoclonal antibodies. He is now Chief Executive Officer at [http://www.najittech.com/index.html Nijit Technologies, Inc.] | ||
Back to [[Hoatlin Lab]] | Back to [[Hoatlin Lab]] | ||
Revision as of 20:48, 2 July 2006
Former Team Members
- still filling in the details....
- Bendert de Graaf, B.S., M.S.
- Michael Wallisch, Ph.D.
- Margriet van Kogelenberg, B.S.
- Ingrid Bijsmans, B.S., M.S.
- Tanja Reuter, Ph.D
- Melud Nabavi
- Yu Zhi
- Paul Yoshihara, PhD. worked with us to make several monoclonal antibodies. He is now Chief Executive Officer at Nijit Technologies, Inc.
Back to Hoatlin Lab
